drugset / Trial / NCT00257023
An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety, effectiveness, and plasma concentration of paliperidone (an antipsychotic medication) given once daily in the treatment of patients with schizophrenia
Timeline
- Start
- 2005-02
- Primary completion
- —
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paliperidone | Unknown | 3 mg | Oral |
| Subject | Paliperidone | Unknown | 9 mg | Oral |
| Subject | Paliperidone | Unknown | 15 mg | Oral |